Vistagen Therapeutics, Inc. (VTGN) Insider Ownership

Historic Insider Ownership Trends

As of April 17, 2026, the three largest insider holders of VTGN are Healthcare Capital Partners Ii, L.P. Venrock (TenPercentOwner, 20.64Mn shares), Healthcare Capital Partners Ii, L.P. Venrock (TenPercentOwner, 20.64Mn shares), Healthcare Capital Partners Ii, L.P. Venrock (TenPercentOwner, 20.64Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Healthcare Capital Partners Ii, L.P. Venrock - 0 20,637,286 14 Jul, 2022
Healthcare Capital Partners Ii, L.P. Venrock - 0 20,637,286 14 Jul, 2022
Healthcare Capital Partners Ii, L.P. Venrock - 0 20,637,286 14 Jul, 2022
Capital Lp Commodore - 0 1,575,000 09 Aug, 2023
Shawn Singh Chief Executive Officer 0 626,234 18 Aug, 2022
Jerry B Gin - 100,000 100,000 22 Aug, 2022
H. Ralph Snodgrass Pres./Chief Scientific Officer 64,958 0 03 Jan, 2022
H. Ralph Snodgrass Pres./Chief Scientific Officer 0 33,901 03 Sep, 2021
Reid G. Adler Chief Legal Officer 24,050 0 01 Jul, 2025
Mark Alan Smith Chief Medical Officer 19,915 0 15 Jul, 2022
Shawn Singh President And Ceo 18,028 0 01 Jul, 2025
Joshua S. Prince Chief Operating Officer 15,249 0 05 Jan, 2026
Cynthia Lynn Anderson Chief Financial Officer 12,801 0 01 Jul, 2025
Jerrold Duane Dotson Vp, Cfo 3,671 0 05 Jul, 2023

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
07 Apr, 2026 Shawn Singh Incentive Stock Option (right to buy) A 3,732 $0.00 3,732 D A
07 Apr, 2026 Joshua S. Prince Incentive Stock Option (right to buy) A 18,752 $0.00 18,752 D A
07 Apr, 2026 Elissa S. Cote Incentive Stock Option (right to buy) A 75,000 $0.00 75,000 D A
07 Apr, 2026 Nick B. Tressler Incentive Stock Option (right to buy) A 75,000 $0.00 75,000 D A
07 Apr, 2026 Reid G. Adler Incentive Stock Option (right to buy) A 18,753 $0.00 18,753 D A
07 Apr, 2026 Shawn Singh Non-Qualified Stock Option (right to buy) A 71,268 $0.00 71,268 D A
07 Apr, 2026 Joshua S. Prince Non-Qualified Stock Option (right to buy) A 56,248 $0.00 56,248 D A
07 Apr, 2026 Reid G. Adler Non-Qualified Stock Option (right to buy) A 56,247 $0.00 56,247 D A
31 Dec, 2025 Joshua S. Prince Common Stock A 4,386 $0.56 15,249 D A
01 Dec, 2025 Nick B. Tressler Common Stock (Right to Buy) A 150,000 - 150,000 D A
27 Oct, 2025 Paul R Edick Stock Option (Right to Buy) A 35,200 - 35,200 D A
09 Sep, 2025 Joanne Curley Non-Qualified Stock Option (right to buy) A 17,600 $0.00 17,600 D A
09 Sep, 2025 Jon S Saxe Non-Qualified Stock Option (right to buy) A 17,600 $0.00 17,600 D A
09 Sep, 2025 Mary L. Rotunno Non-Qualified Stock Option (right to buy) A 17,600 $0.00 17,600 D A
09 Sep, 2025 Ann Michelle Cunningham Non-Qualified Stock Option (right to buy) A 17,600 $0.00 17,600 D A
09 Sep, 2025 Margaret M Fitzpatrick Non-Qualified Stock Option (right to buy) A 17,600 $0.00 17,600 D A
30 Jun, 2025 Shawn Singh Common Stock A 7,541 $1.70 18,028 D A
30 Jun, 2025 Reid G. Adler Common Stock A 7,541 $1.70 24,050 D A
30 Jun, 2025 Cynthia Lynn Anderson Common Stock A 6,617 $1.70 12,801 D A
30 Jun, 2025 Joshua S. Prince Common Stock A 4,882 $1.70 10,863 D A